With a focus on the Psychiatry & Neurology and Oncology as priority disease areas, Sumitomo Pharma Group (the “Group”) will contribute to the betterment of healthcare and fuller lives of people worldwide through diverse approaches, including pharmaceutical products and Regenerative Medicine/Cell Therapy. In other areas, too, the Group will leverage its assets to deliver value to patients. With this, the Group aims to establish itself as a Global Specialized Player by 2033.



Showcase Sumitomo Pharma in a nutshell
Here you can search for the strengths of Sumitomo Pharma’s business, Sumitomo Pharma’s initiatives, and other information that interests you by selecting tags.
Strengths Sumitomo Pharma’s Three Strengths
- 1R&D Capabilities
- 2Human Resources
- 3Global Business Platforms
Press Releases
- May 19, 2025 Posted conference on FY2024 Financial Results and Reboot 2027 – Reboot for a Strong Sumitomo Pharma – [Webcast] Finances
- May 13, 2025 Presentation Material (Conference on FY2024 Financial Results and Reboot 2027 – Reboot for a Strong Sumitomo Pharma –)(PDF/4,377KB) Finances
- May 13, 2025 Supplementary Financial Data (IFRS) for the Year Ended March 31, 2025(PDF/500KB) Finances
- May 13, 2025 Summary of Consolidated Financial Results for the Year Ended March 31, 2025 [IFRS](PDF/745KB) Finances
- May 13, 2025 Sumitomo Pharma Announces Reboot 2027 – Reboot for a Strong Sumitomo Pharma – Finances
Notices
- Jun. 28, 2024 Consolidated Financial Statements for Years ended March 31, 2024 and 2023 Finances
- May 30, 2024 Posted Notice of Convocation of the 204th Annual Shareholders' Meeting Corporate
- Nov. 30, 2023 Posted Fact Book 2023 ver.2 Others
For the Press
Our latest press releases and other information for members of the press,
including various data sets and guidelines for their use.
-
Sustainability
Sumitomo Pharma defines the practice of its Mission, “To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide,” as Sustainability Management. To this end , Sumitomo Pharma is pursuing Sustainability Management through a variety of initiatives, including the development of innovative products and healthcare solutions, and contribution to the development of science.
-
About Us
Message from the President, corporate profile of Sumitomo Pharma, business activities, mid-term management plan, key locations and group companies, etc.
-
Investor Relations
Information for shareholders and investors of Sumitomo Pharma, including management policies, IR materials, and stock and shareholder-related information.